What might cancer treatment teach us about dealing with retinal disease?

Tuesday, July 1, 2025 - 15:49 in Health & Medicine

Health What might cancer treatment teach us about dealing with retinal disease? Joan Miller’s innovative thinking led to therapies for macular degeneration that have helped millions, made her better leader Sy Boles Harvard Staff Writer June 24, 2025 6 min read Part of the Profiles of Progress series Joan Miller says retinal surgeons tend to be a pretty open-minded bunch.  “We’re willing to try new surgical techniques,” she said. “We’re always trying to push the envelope and the technology. It’s just a very innovative specialty.” Miller is a good example. That brand of independent thinking has been a hallmark of her distinguished career as a researcher, clinician, and leader. Miller, the David Glendenning Cogan Professor of Ophthalmology and chair of the Department of Ophthalmology at Harvard Medical School, is credited with developing two major treatments for age-related macular degeneration (AMD), the most common cause of vision loss in people over the age of 50. Her treatments are administered to millions of patients...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net